Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10)

  1. Siefker-Radtke, A.O.
  2. Huddart, R.A.
  3. Bilen, M.A.
  4. Balar, A.
  5. Castellano, D.
  6. Sridhar, S.S.
  7. De Giorgi, U.
  8. Penkov, K.
  9. Vasiliev, A.
  10. Peer, A.
  11. Järvinen, R.
  12. Harputluoğlu, H.
  13. Koshkin, V.S.
  14. Poushnejad, S.
  15. Wang, T.
  16. Qureshi, A.
  17. Tagliaferri, M.A.
  18. Zalevsky, J.
  19. Loriot, Y.
Revista:
Urologic Oncology: Seminars and Original Investigations

ISSN: 1873-2496 1078-1439

Any de publicació: 2024

Tipus: Article

DOI: 10.1016/J.UROLONC.2024.09.030 GOOGLE SCHOLAR